References

Heart failure in children: part I: history, etiology, and pathophysiology

10.1161/circheartfailure.108.820217 · 2009 · External reference

Heart failure in children: part II: diagnosis, treatment, and future directions

10.1161/circheartfailure.109.856229 · 2009 · External reference

Pathophysiology and molecular signaling in pediatric heart failure and VAD therapy

10.1016/j.cca.2020.09.010 · 2020 · External reference

Prevalence, morbidity, and mortality of heart failure-related hospitalizations in children in the United States: a population-based study

10.1016/j.cardfail.2012.03.001 · 2012 · External reference

The International Society for Heart and Lung Transplantation Guidelines for the management of pediatric heart failure: executive summary

10.1016/j.healun.2014.06.002 · 2014 · External reference

Heart rate reduction as a marker to optimize carvedilol treatment and enhance myocardial recovery in pediatric dilated cardiomyopathy

10.3389/fphys.2022.1001752 · 2022 · External reference

Pediatric heart transplant waiting list mortality in the era of ventricular assist devices

10.1016/j.healun.2014.09.018 · 2015 · External reference

Novel epigenetic-based therapies useful in cardiovascular medicine

10.4330/wjc.v8.i2.211 · 2016 · External reference

Epigenetic regulation of cardiac troponin genes in pediatric patients with heart failure supported by ventricular assist device

10.3390/biomedicines9101409 · 2021 · External reference

Adiponectin in the heart and vascular system

10.1016/b978-0-12-398313-8.00011-7 · 2012 · External reference

The role of cardiac T-cadherin in the indicating heart failure severity of patients with non-ischemic dilated cardiomyopathy

10.3390/medicina56010027 · 2020 · External reference

Adiponectin protects against myocardial ischemia-reperfusion injury through ampk- and cox-2-dependent mechanisms

10.1038/nm1295 · 2005 · External reference

Adiponectin level and left ventricular hypertrophy in Japanese men

10.1161/hypertensionaha.106.079509 · 2007 · External reference

Can adiponectin be a novel metabolic biomarker for heart failure?

10.1253/circj.cj-09-0235 · 2009 · External reference

Back to the heart: the protective role of adiponectin

10.1016/j.phrs.2014.03.003 · 2014 · External reference

Regional evidence of modulation of cardiac adiponectin level in dilated cardiomyopathy: pilot study in a porcine animal model

10.1186/1475-2840-11-143 · 2012 · External reference

T-cadherin is critical for adiponectin-mediated cardioprotection in mice

10.1172/jci43464 · 2010 · External reference

Cloning of adiponectin receptors that mediate antidiabetic metabolic effects

10.1038/nature01705 · 2003 · External reference

Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure

10.1161/circulationaha.104.530972 · 2005 · External reference

Adiponectin and cardiovascular disease

10.1253/circj.cj-09-0057 · 2009 · External reference

Role of adipokines in cardiovascular disease

10.1530/joe-12-0232 · 2013 · External reference

Between inflammation and autophagy: the role of leptin-adiponectin axis in cardiac remodeling

10.2147/jir.s322231 · 2021 · External reference

MicroRNA-150 inhibits expression of adiponectin receptor 2 and is a potential therapeutic target in patients with chronic heart failure

10.1016/j.healun.2013.10.014 · 2014 · External reference

Adipose tissue inflammation and adiponectin resistance in patients with advanced heart failure: correction after ventricular assist device implantation

10.1161/circheartfailure.111.964031 · 2012 · External reference

Adiponectin plasma levels decrease after surgery in pediatric patients with congenital heart disease

10.1016/j.clinbiochem.2012.07.096 · 2012 · External reference

Time-course of circulating cardiac and inflammatory biomarkers after ventricular assist device implantation: comparison between paediatric and adult patients

10.1016/j.cca.2018.07.036 · 2018 · External reference

AdipoRon, an adiponectin receptor agonist, attenuates cardiac remodeling induced by pressure overload

10.1007/s00109-018-1696-8 · 2018 · External reference

Endogenously produced adiponectin protects cardiomyocytes from hypertrophy by a PPARgamma-dependent autocrine mechanism

10.1152/ajpheart.01032.2009 · 2010 · External reference

G-protein-coupled receptor kinase 2-mediated desensitization of adiponectin receptor 1 in failing heart

10.1161/circulationaha.114.015248 · 2015 · External reference

The role of cardiac T-cadherin in the indicating heart failure severity of patients with non-ischemic dilated cardiomyopathy

10.3390/medicina56010027 · 2020 · External reference

Reciprocal regulation of myocardial microRNAs and messenger RNA in human cardiomyopathy and reversal of the microRNA signature by biomechanical support

10.1161/circulationaha.108.813576 · 2009 · External reference

A deep sequencing approach to uncover the miRNOME in the human heart

10.1371/annotation/e33f9763-3385-42c7-b31e-d433dc8e499a · 2013 · External reference